Brenda Libby Coleman

Array ( [id] => 8830290 [patent_doc_number] => 20130131335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'METHODS FOR THE PREPARATION OF DROSPIRENONE AND INTERMEDIATES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/813195 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7098 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842051 [patent_doc_number] => 20130137679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'Novel Functionally Selective Ligands of Dopamine D2 Receptors' [patent_app_type] => utility [patent_app_number] => 13/807347 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 36521 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511452 [patent_doc_number] => 20110257162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'HIV INTEGRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/172393 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45243 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257162.pdf [firstpage_image] =>[orig_patent_app_number] => 13172393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780801 [patent_doc_number] => 20130102777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2--ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID' [patent_app_type] => utility [patent_app_number] => 13/805607 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1682 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587337 [patent_doc_number] => 20110281847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS' [patent_app_type] => utility [patent_app_number] => 13/167343 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37920 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281847.pdf [firstpage_image] =>[orig_patent_app_number] => 13167343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503577 [patent_doc_number] => 08741891 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-06-03 [patent_title] => 'N-substituted noribogaine prodrugs' [patent_app_type] => utility [patent_app_number] => 13/165626 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17131 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8733766 [patent_doc_number] => 20130079335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'Benzotriazolodiazepine Compounds Inhibitors Of Bromodomains' [patent_app_type] => utility [patent_app_number] => 13/702177 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19560 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657331 [patent_doc_number] => 20110306600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'NOVEL THERAPEUTIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/157347 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4562 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306600.pdf [firstpage_image] =>[orig_patent_app_number] => 13157347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574089 [patent_doc_number] => 20110269745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => '6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/156575 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74454 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269745.pdf [firstpage_image] =>[orig_patent_app_number] => 13156575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884829 [patent_doc_number] => 20130158013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'PROCESSES FOR THE PREPARATION OF 5-HT2C RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/701471 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14746 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016721 [patent_doc_number] => 20110224194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Staurosporine Derivatives as Inhibitors of FLT3 Receptor Tyrosine Kinase Activity' [patent_app_type] => utility [patent_app_number] => 13/109511 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21603 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224194.pdf [firstpage_image] =>[orig_patent_app_number] => 13109511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733490 [patent_doc_number] => 20120015925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/108394 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 335791 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015925.pdf [firstpage_image] =>[orig_patent_app_number] => 13108394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629935 [patent_doc_number] => 08362007 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-01-29 [patent_title] => 'Substituted noribogaine' [patent_app_type] => utility [patent_app_number] => 13/104410 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11692 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13104410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940692 [patent_doc_number] => 20130190489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/643133 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9464 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982124 [patent_doc_number] => 08513238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes' [patent_app_type] => utility [patent_app_number] => 13/101173 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49966 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13101173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6049088 [patent_doc_number] => 20110207925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/100601 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3521 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207925.pdf [firstpage_image] =>[orig_patent_app_number] => 13100601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540582 [patent_doc_number] => 08058425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Purine derivatives as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/100618 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59803 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058425.pdf [firstpage_image] =>[orig_patent_app_number] => 13100618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561966 [patent_doc_number] => 20110275799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'PROCESS FOR THE SYNTHESIS OF 4H-IMIDAZO [1,5-a] [1,4] BENZODIAZEPINES, IN PARTICULAR MIDAZOLAM AND SALTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/099820 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3549 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275799.pdf [firstpage_image] =>[orig_patent_app_number] => 13099820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355361 [patent_doc_number] => 08673894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => '2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds' [patent_app_type] => utility [patent_app_number] => 13/096059 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53334 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995920 [patent_doc_number] => 09040518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Chemical compounds' [patent_app_type] => utility [patent_app_number] => 13/640166 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49492 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640166 [rel_patent_id] =>[rel_patent_doc_number] =>)